Drugs / GEN-004
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01995617 | Nov 2013 → Feb 2015 | pneumococcal infection | Genocea Biosciences, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02116998 | Sep 2014 → Apr 2016 | streptococcal pneumonia | Genocea Biosciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEN-004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01995617 ↗ |
| Modality | Vaccine | “GEN-004, a Streptococcus Pneumoniae Protein Subunit Vaccine” NCT01995617 ↗ |